Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
28801
28802
28803
28804
28805
28806
28807
28808
28809
28810
28811
28812
28813
28814
28815
28816
28817
28818
28819
28820
28821
28822
28823
28824
28825
28826
28827
28828
28829
28830
28831
28832
28833
28834
28835
28836
28837
28838
28839
28840
28841
28842
28843
28844
28845
28846
28847
28848
28849
28850
28851
28852
28853
28854
28855
28856
28857
28858
28859
28860
28861
28862
28863
28864
28865
28866
28867
28868
28869
28870
28871
28872
28873
28874
28875
28876
28877
28878
28879
28880
28881
28882
28883
28884
28885
28886
28887
28888
28889
28890
28891
28892
28893
28894
28895
28896
28897
28898
28899
28900
28901
28902
28903
28904
28905
28906
28907
28908
28909
28910
28911
28912
28913
28914
28915
28916
28917
28918
28919
28920
28921
28922
28923
28924
28925
28926
28927
28928
28929
28930
28931
28932
28933
28934
28935
28936
28937
28938
28939
28940
28941
28942
28943
28944
28945
28946
28947
28948
28949
28950
28951
28952
28953
28954
28955
28956
28957
28958
28959
28960
28961
28962
28963
28964
28965
28966
28967
28968
28969
28970
28971
28972
28973
28974
28975
28976
28977
28978
28979
28980
28981
28982
28983
28984
28985
28986
28987
28988
28989
28990
28991
28992
28993
28994
28995
28996
28997
28998
28999
29000
| UnnamedSample_HQ_transcript/90394|m.21312 | UnnamedSample_HQ_transcript/90394 | Coverage 0.388 too low. | 764526eed7f366a1e2561477c84bbc12 | 175 | Pfam | PF05644 | Mitochondrial and peroxisomal fission factor Mff | 15 | 154 | 5.2E-33 | T | 22-09-2020 | IPR039433 | Mff-like domain |
| UnnamedSample_HQ_transcript/82958|m.20191 | UnnamedSample_HQ_transcript/82958 | Coverage 0.989 too low. | 892db4afa62ce262a22e7d823b8b8549 | 409 | Pfam | PF12605 | Casein kinase 1 gamma C terminal | 367 | 391 | 2.1E-9 | T | 22-09-2020 | IPR022247 | Casein kinase 1 gamma C-terminal |
| UnnamedSample_HQ_transcript/82958|m.20191 | UnnamedSample_HQ_transcript/82958 | Coverage 0.989 too low. | 892db4afa62ce262a22e7d823b8b8549 | 409 | Pfam | PF00069 | Protein kinase domain | 52 | 265 | 5.9E-27 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/100089|m.22655 | UnnamedSample_HQ_transcript/100089 | Coverage 0.932 too low. | bf4bb876ef7c281adaeda25a02dd37f1 | 238 | Pfam | PF02898 | Nitric oxide synthase, oxygenase domain | 1 | 238 | 8.3E-125 | T | 22-09-2020 | IPR004030 | Nitric oxide synthase, N-terminal |
| UnnamedSample_HQ_transcript/92422|m.21595 | UnnamedSample_HQ_transcript/92422 | Coverage 0.340 too low. | 14b6532d5c2bc7791d88b3c1c9d72f76 | 417 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 123 | 417 | 5.4E-61 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/14330|m.5205 | UnnamedSample_HQ_transcript/14330 | Coverage 0.358 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 167 | 288 | 3.6E-18 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/14330|m.5205 | UnnamedSample_HQ_transcript/14330 | Coverage 0.358 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 339 | 456 | 2.1E-17 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/17443|m.6137 | UnnamedSample_HQ_transcript/17443 | Coverage 0.401 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 167 | 288 | 3.6E-18 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/17443|m.6137 | UnnamedSample_HQ_transcript/17443 | Coverage 0.401 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 339 | 456 | 2.1E-17 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/27807|m.8918 | UnnamedSample_HQ_transcript/27807 | Coverage 0.195 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 167 | 288 | 3.6E-18 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/27807|m.8918 | UnnamedSample_HQ_transcript/27807 | Coverage 0.195 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 339 | 456 | 2.1E-17 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/20243|m.6932 | UnnamedSample_HQ_transcript/20243 | Coverage 0.158 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 167 | 288 | 3.6E-18 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/20243|m.6932 | UnnamedSample_HQ_transcript/20243 | Coverage 0.158 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 339 | 456 | 2.1E-17 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/13426|m.4933 | UnnamedSample_HQ_transcript/13426 | Coverage 0.370 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 167 | 288 | 3.6E-18 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/13426|m.4933 | UnnamedSample_HQ_transcript/13426 | Coverage 0.370 too low. | 1c1d418223e2880600fa5b5c7cee5d2e | 474 | Pfam | PF00188 | Cysteine-rich secretory protein family | 339 | 456 | 2.1E-17 | T | 22-09-2020 | IPR014044 | CAP domain |
| UnnamedSample_HQ_transcript/6351|m.2654 | UnnamedSample_HQ_transcript/6351 | Coverage 0.969 too low. | 9830aa96d764d935f3dd42ee388609b9 | 1084 | Pfam | PF00856 | SET domain | 344 | 449 | 3.7E-20 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/6351|m.2654 | UnnamedSample_HQ_transcript/6351 | Coverage 0.969 too low. | 9830aa96d764d935f3dd42ee388609b9 | 1084 | Pfam | PF17907 | AWS domain | 296 | 330 | 4.6E-10 | T | 22-09-2020 | IPR006560 | AWS domain |
| UnnamedSample_HQ_transcript/6351|m.2654 | UnnamedSample_HQ_transcript/6351 | Coverage 0.969 too low. | 9830aa96d764d935f3dd42ee388609b9 | 1084 | Pfam | PF00397 | WW domain | 992 | 1021 | 3.5E-9 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/73603|m.18589 | UnnamedSample_HQ_transcript/73603 | Coverage 0.844 too low. | 649ca24670d5525dcc7b0ca2cba66fbd | 288 | Pfam | PF01553 | Acyltransferase | 91 | 217 | 3.2E-21 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/1379|m.797 | UnnamedSample_HQ_transcript/1379 | Coverage 0.808 too low. | 9e70c9990da9fdfd59351d38cb403bf1 | 1788 | Pfam | PF09128 | Regulator of G protein signalling-like domain | 532 | 719 | 1.4E-49 | T | 22-09-2020 | IPR015212 | Regulator of G protein signalling-like domain |
| UnnamedSample_HQ_transcript/1379|m.797 | UnnamedSample_HQ_transcript/1379 | Coverage 0.808 too low. | 9e70c9990da9fdfd59351d38cb403bf1 | 1788 | Pfam | PF00621 | RhoGEF domain | 1072 | 1255 | 1.1E-38 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/1379|m.797 | UnnamedSample_HQ_transcript/1379 | Coverage 0.808 too low. | 9e70c9990da9fdfd59351d38cb403bf1 | 1788 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 761 | 811 | 4.9E-11 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/1379|m.797 | UnnamedSample_HQ_transcript/1379 | Coverage 0.808 too low. | 9e70c9990da9fdfd59351d38cb403bf1 | 1788 | Pfam | PF17838 | PH domain | 1287 | 1417 | 2.4E-29 | T | 22-09-2020 | IPR041020 | ARHGEF1-like, PH domain |
| UnnamedSample_HQ_transcript/1379|m.797 | UnnamedSample_HQ_transcript/1379 | Coverage 0.808 too low. | 9e70c9990da9fdfd59351d38cb403bf1 | 1788 | Pfam | PF00595 | PDZ domain | 62 | 133 | 1.4E-17 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/98000|m.22366 | UnnamedSample_HQ_transcript/98000 | Identity 0.948 too low. | 7dda1c4043ee06757a7e276f75c82cf8 | 351 | Pfam | PF01223 | DNA/RNA non-specific endonuclease | 230 | 344 | 5.2E-16 | T | 22-09-2020 | IPR001604 | DNA/RNA non-specific endonuclease |
| UnnamedSample_HQ_transcript/938|m.607 | UnnamedSample_HQ_transcript/938 | Coverage 0.917 too low. | c71dbe6b1782d95912ff9dd218b8b42e | 1187 | Pfam | PF14765 | Polyketide synthase dehydratase | 31 | 227 | 2.6E-11 | T | 22-09-2020 | IPR020807 | Polyketide synthase, dehydratase domain |
| UnnamedSample_HQ_transcript/938|m.607 | UnnamedSample_HQ_transcript/938 | Coverage 0.917 too low. | c71dbe6b1782d95912ff9dd218b8b42e | 1187 | Pfam | PF00107 | Zinc-binding dehydrogenase | 726 | 845 | 5.7E-19 | T | 22-09-2020 | IPR013149 | Alcohol dehydrogenase, C-terminal |
| UnnamedSample_HQ_transcript/938|m.607 | UnnamedSample_HQ_transcript/938 | Coverage 0.917 too low. | c71dbe6b1782d95912ff9dd218b8b42e | 1187 | Pfam | PF08659 | KR domain | 934 | 1112 | 9.9E-45 | T | 22-09-2020 | IPR013968 | Polyketide synthase, ketoreductase domain |
| UnnamedSample_HQ_transcript/4959|m.2176 | UnnamedSample_HQ_transcript/4959 | Coverage 0.444 too low. | 449446c44e6720f8958e57eb017bb2fb | 1215 | Pfam | PF19056 | WD40 repeated domain | 874 | 1089 | 5.0E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4959|m.2176 | UnnamedSample_HQ_transcript/4959 | Coverage 0.444 too low. | 449446c44e6720f8958e57eb017bb2fb | 1215 | Pfam | PF16471 | JNK-interacting protein leucine zipper II | 248 | 318 | 1.2E-30 | T | 22-09-2020 | IPR032486 | JNK-interacting protein, leucine zipper II |
| UnnamedSample_HQ_transcript/4959|m.2176 | UnnamedSample_HQ_transcript/4959 | Coverage 0.444 too low. | 449446c44e6720f8958e57eb017bb2fb | 1215 | Pfam | PF09744 | JNK_SAPK-associated protein-1 | 5 | 49 | 1.9E-7 | T | 22-09-2020 | IPR019143 | JNK/Rab-associated protein-1, N-terminal |
| UnnamedSample_HQ_transcript/97384|m.22287 | UnnamedSample_HQ_transcript/97384 | Identity 0.933 too low. | e4fa4dd345d1378b164329904972509c | 115 | Pfam | PF02535 | ZIP Zinc transporter | 1 | 110 | 2.2E-19 | T | 22-09-2020 | IPR003689 | Zinc/iron permease |
| UnnamedSample_HQ_transcript/77809|m.19341 | UnnamedSample_HQ_transcript/77809 | Coverage 0.901 too low. | c7c4c9c08cccb8e9b20f3225908f69b0 | 320 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 24 | 90 | 6.1E-10 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/77809|m.19341 | UnnamedSample_HQ_transcript/77809 | Coverage 0.901 too low. | c7c4c9c08cccb8e9b20f3225908f69b0 | 320 | Pfam | PF14559 | Tetratricopeptide repeat | 237 | 300 | 1.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/76890|m.19183 | UnnamedSample_HQ_transcript/76890 | Coverage 0.911 too low. | c7c4c9c08cccb8e9b20f3225908f69b0 | 320 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 24 | 90 | 6.1E-10 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/76890|m.19183 | UnnamedSample_HQ_transcript/76890 | Coverage 0.911 too low. | c7c4c9c08cccb8e9b20f3225908f69b0 | 320 | Pfam | PF14559 | Tetratricopeptide repeat | 237 | 300 | 1.3E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/32317|m.10035 | UnnamedSample_HQ_transcript/32317 | Coverage 0.983 too low. | 109383cfd78cede25883905ba7ec4c82 | 225 | Pfam | PF08337 | Plexin cytoplasmic RasGAP domain | 1 | 193 | 6.6E-105 | T | 22-09-2020 | IPR013548 | Plexin, cytoplasmic RasGAP domain |
| UnnamedSample_HQ_transcript/65132|m.17054 | UnnamedSample_HQ_transcript/65132 | Coverage 0.702 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13424 | Tetratricopeptide repeat | 216 | 290 | 2.2E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/65132|m.17054 | UnnamedSample_HQ_transcript/65132 | Coverage 0.702 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13424 | Tetratricopeptide repeat | 299 | 373 | 5.7E-21 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/65132|m.17054 | UnnamedSample_HQ_transcript/65132 | Coverage 0.702 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13176 | Tetratricopeptide repeat | 388 | 415 | 2.7E-4 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/65132|m.17054 | UnnamedSample_HQ_transcript/65132 | Coverage 0.702 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13374 | Tetratricopeptide repeat | 468 | 501 | 1.2E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/48631|m.13721 | UnnamedSample_HQ_transcript/48631 | Coverage 0.737 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13424 | Tetratricopeptide repeat | 216 | 290 | 2.2E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/48631|m.13721 | UnnamedSample_HQ_transcript/48631 | Coverage 0.737 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13424 | Tetratricopeptide repeat | 299 | 373 | 5.7E-21 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/48631|m.13721 | UnnamedSample_HQ_transcript/48631 | Coverage 0.737 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13176 | Tetratricopeptide repeat | 388 | 415 | 2.7E-4 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/48631|m.13721 | UnnamedSample_HQ_transcript/48631 | Coverage 0.737 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13374 | Tetratricopeptide repeat | 468 | 501 | 1.2E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/44890|m.12889 | UnnamedSample_HQ_transcript/44890 | Coverage 0.336 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13424 | Tetratricopeptide repeat | 216 | 290 | 2.2E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/44890|m.12889 | UnnamedSample_HQ_transcript/44890 | Coverage 0.336 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13424 | Tetratricopeptide repeat | 299 | 373 | 5.7E-21 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/44890|m.12889 | UnnamedSample_HQ_transcript/44890 | Coverage 0.336 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13176 | Tetratricopeptide repeat | 388 | 415 | 2.7E-4 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/44890|m.12889 | UnnamedSample_HQ_transcript/44890 | Coverage 0.336 too low. | bb5eb705e50ae37e7ec10a18380d9161 | 557 | Pfam | PF13374 | Tetratricopeptide repeat | 468 | 501 | 1.2E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/109035|m.23716 | UnnamedSample_HQ_transcript/109035 | Coverage 0.940 too low. | 616ffc145d6c58c5bac775c041f21d16 | 290 | Pfam | PF00096 | Zinc finger, C2H2 type | 86 | 109 | 0.0043 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/109035|m.23716 | UnnamedSample_HQ_transcript/109035 | Coverage 0.940 too low. | 616ffc145d6c58c5bac775c041f21d16 | 290 | Pfam | PF00096 | Zinc finger, C2H2 type | 6 | 26 | 4.0E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/109035|m.23716 | UnnamedSample_HQ_transcript/109035 | Coverage 0.940 too low. | 616ffc145d6c58c5bac775c041f21d16 | 290 | Pfam | PF12874 | Zinc-finger of C2H2 type | 124 | 143 | 0.047 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8114|m.3229 | UnnamedSample_HQ_transcript/8114 | Coverage 0.970 too low. | f6c25a7660e3c917bca9baa9d5a9bbbd | 990 | Pfam | PF08314 | Secretory pathway protein Sec39 | 171 | 414 | 8.2E-13 | T | 22-09-2020 | IPR013244 | Sec39 domain |
| UnnamedSample_HQ_transcript/61902|m.16429 | UnnamedSample_HQ_transcript/61902 | Coverage 0.266 too low. | 5a1a80a68d110d5f8d2765cc48ed8109 | 560 | Pfam | PF00012 | Hsp70 protein | 5 | 557 | 1.9E-218 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/71654|m.18240 | UnnamedSample_HQ_transcript/71654 | Coverage 0.715 too low. | 7e5c9eec32e60620245832cd6ed67b8b | 197 | Pfam | PF00622 | SPRY domain | 67 | 177 | 3.2E-25 | T | 22-09-2020 | IPR003877 | SPRY domain |
| UnnamedSample_HQ_transcript/107480|m.23519 | UnnamedSample_HQ_transcript/107480 | Coverage 0.989 too low. | 96de5f31c54e1c8441cb4db0ad8aaf0c | 239 | Pfam | PF01088 | Ubiquitin carboxyl-terminal hydrolase, family 1 | 15 | 216 | 1.7E-67 | T | 22-09-2020 | IPR001578 | Peptidase C12, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/20656|m.7053 | UnnamedSample_HQ_transcript/20656 | Coverage 0.979 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 394 | 486 | 4.7E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/20656|m.7053 | UnnamedSample_HQ_transcript/20656 | Coverage 0.979 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF01363 | FYVE zinc finger | 167 | 223 | 1.5E-16 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/20656|m.7053 | UnnamedSample_HQ_transcript/20656 | Coverage 0.979 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF00790 | VHS domain | 11 | 142 | 1.9E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/17907|m.6274 | UnnamedSample_HQ_transcript/17907 | Identity 0.947 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 394 | 486 | 4.7E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/17907|m.6274 | UnnamedSample_HQ_transcript/17907 | Identity 0.947 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF01363 | FYVE zinc finger | 167 | 223 | 1.5E-16 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/17907|m.6274 | UnnamedSample_HQ_transcript/17907 | Identity 0.947 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF00790 | VHS domain | 11 | 142 | 1.9E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/21227|m.7207 | UnnamedSample_HQ_transcript/21227 | Identity 0.944 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 394 | 486 | 4.7E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/21227|m.7207 | UnnamedSample_HQ_transcript/21227 | Identity 0.944 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF01363 | FYVE zinc finger | 167 | 223 | 1.5E-16 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/21227|m.7207 | UnnamedSample_HQ_transcript/21227 | Identity 0.944 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF00790 | VHS domain | 11 | 142 | 1.9E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/21739|m.7352 | UnnamedSample_HQ_transcript/21739 | Identity 0.944 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 394 | 486 | 4.7E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/21739|m.7352 | UnnamedSample_HQ_transcript/21739 | Identity 0.944 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF01363 | FYVE zinc finger | 167 | 223 | 1.5E-16 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/21739|m.7352 | UnnamedSample_HQ_transcript/21739 | Identity 0.944 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF00790 | VHS domain | 11 | 142 | 1.9E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/24848|m.8179 | UnnamedSample_HQ_transcript/24848 | Coverage 0.977 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF12210 | Hepatocyte growth factor-regulated tyrosine kinase substrate | 394 | 486 | 4.7E-40 | T | 22-09-2020 | IPR024641 | Hepatocyte growth factor-regulated tyrosine kinase substrate, helical domain |
| UnnamedSample_HQ_transcript/24848|m.8179 | UnnamedSample_HQ_transcript/24848 | Coverage 0.977 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF01363 | FYVE zinc finger | 167 | 223 | 1.5E-16 | T | 22-09-2020 | IPR000306 | FYVE zinc finger |
| UnnamedSample_HQ_transcript/24848|m.8179 | UnnamedSample_HQ_transcript/24848 | Coverage 0.977 too low. | 060d83ce0bcca6b145f3daaa15083914 | 826 | Pfam | PF00790 | VHS domain | 11 | 142 | 1.9E-37 | T | 22-09-2020 | IPR002014 | VHS domain |
| UnnamedSample_HQ_transcript/19903|m.6843 | UnnamedSample_HQ_transcript/19903 | Coverage 0.843 too low. | dc2725c217211dbd11fb86d22614ec03 | 992 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 766 | 8.5E-285 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/19903|m.6843 | UnnamedSample_HQ_transcript/19903 | Coverage 0.843 too low. | dc2725c217211dbd11fb86d22614ec03 | 992 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 2.4E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/94704|m.21909 | UnnamedSample_HQ_transcript/94704 | Coverage 0.971 too low. | cb0c3882bf5f650f3c8bfb7587334109 | 361 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 34 | 187 | 4.6E-16 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/94704|m.21909 | UnnamedSample_HQ_transcript/94704 | Coverage 0.971 too low. | cb0c3882bf5f650f3c8bfb7587334109 | 361 | Pfam | PF00183 | Hsp90 protein | 190 | 352 | 3.5E-53 | T | 22-09-2020 | IPR001404 | Heat shock protein Hsp90 family |
| UnnamedSample_HQ_transcript/98664|m.22453 | UnnamedSample_HQ_transcript/98664 | Coverage 0.988 too low. | b40a8a253fac467e94144952f7682a90 | 327 | Pfam | PF00128 | Alpha amylase, catalytic domain | 3 | 109 | 6.5E-14 | T | 22-09-2020 | IPR006047 | Glycosyl hydrolase, family 13, catalytic domain |
| UnnamedSample_HQ_transcript/11637|m.4372 | UnnamedSample_HQ_transcript/11637 | Coverage 0.909 too low. | 33e3fd9353c123fb67cb332ac32486c9 | 1253 | Pfam | PF00204 | DNA gyrase B | 268 | 428 | 6.3E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/11637|m.4372 | UnnamedSample_HQ_transcript/11637 | Coverage 0.909 too low. | 33e3fd9353c123fb67cb332ac32486c9 | 1253 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 81 | 225 | 1.4E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/11637|m.4372 | UnnamedSample_HQ_transcript/11637 | Coverage 0.909 too low. | 33e3fd9353c123fb67cb332ac32486c9 | 1253 | Pfam | PF01751 | Toprim domain | 457 | 558 | 7.0E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/11637|m.4372 | UnnamedSample_HQ_transcript/11637 | Coverage 0.909 too low. | 33e3fd9353c123fb67cb332ac32486c9 | 1253 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 573 | 716 | 9.0E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/11637|m.4372 | UnnamedSample_HQ_transcript/11637 | Coverage 0.909 too low. | 33e3fd9353c123fb67cb332ac32486c9 | 1253 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 718 | 1192 | 6.0E-129 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/42727|m.12426 | UnnamedSample_HQ_transcript/42727 | Coverage 0.561 too low. | 61da8b779c2f46701763fd621e7ec7a2 | 445 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 149 | 206 | 3.0E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/42727|m.12426 | UnnamedSample_HQ_transcript/42727 | Coverage 0.561 too low. | 61da8b779c2f46701763fd621e7ec7a2 | 445 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 75 | 138 | 8.9E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/42727|m.12426 | UnnamedSample_HQ_transcript/42727 | Coverage 0.561 too low. | 61da8b779c2f46701763fd621e7ec7a2 | 445 | Pfam | PF08075 | NOPS (NUC059) domain | 219 | 271 | 6.4E-24 | T | 22-09-2020 | IPR012975 | NOPS |
| UnnamedSample_HQ_transcript/35922|m.10913 | UnnamedSample_HQ_transcript/35922 | Coverage 0.979 too low. | 5ec57997222c3d583e2ff201be65bc23 | 408 | Pfam | PF01483 | Proprotein convertase P-domain | 246 | 330 | 3.3E-28 | T | 22-09-2020 | IPR002884 | P domain |
| UnnamedSample_HQ_transcript/35922|m.10913 | UnnamedSample_HQ_transcript/35922 | Coverage 0.979 too low. | 5ec57997222c3d583e2ff201be65bc23 | 408 | Pfam | PF00082 | Subtilase family | 15 | 189 | 3.2E-19 | T | 22-09-2020 | IPR000209 | Peptidase S8/S53 domain |
| UnnamedSample_HQ_transcript/91316|m.21446 | UnnamedSample_HQ_transcript/91316 | Coverage 0.796 too low. | 1a085f8120cc1b4fc3123b056cc7856f | 107 | Pfam | PF00085 | Thioredoxin | 9 | 102 | 1.3E-27 | T | 22-09-2020 | IPR013766 | Thioredoxin domain |
| UnnamedSample_HQ_transcript/92892|m.21645 | UnnamedSample_HQ_transcript/92892 | Coverage 0.770 too low. | 1a085f8120cc1b4fc3123b056cc7856f | 107 | Pfam | PF00085 | Thioredoxin | 9 | 102 | 1.3E-27 | T | 22-09-2020 | IPR013766 | Thioredoxin domain |
| UnnamedSample_HQ_transcript/57360|m.15518 | UnnamedSample_HQ_transcript/57360 | Coverage 0.431 too low. | 2bb635299cef24820766bec46ac940d6 | 608 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 35 | 233 | 6.9E-62 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/57360|m.15518 | UnnamedSample_HQ_transcript/57360 | Coverage 0.431 too low. | 2bb635299cef24820766bec46ac940d6 | 608 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 296 | 533 | 3.3E-41 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/49152|m.13843 | UnnamedSample_HQ_transcript/49152 | Coverage 0.329 too low. | 268f6af498bc02517f0d26c7f72ceeb5 | 617 | Pfam | PF06367 | Diaphanous FH3 Domain | 49 | 230 | 9.6E-29 | T | 22-09-2020 | IPR010472 | Formin, FH3 domain |
| UnnamedSample_HQ_transcript/49152|m.13843 | UnnamedSample_HQ_transcript/49152 | Coverage 0.329 too low. | 268f6af498bc02517f0d26c7f72ceeb5 | 617 | Pfam | PF02181 | Formin Homology 2 Domain | 348 | 616 | 3.4E-60 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/111880|m.24064 | UnnamedSample_HQ_transcript/111880 | Coverage 0.778 too low. | f4631a64de512be9e608b87651aef53d | 200 | Pfam | PF01812 | 5-formyltetrahydrofolate cyclo-ligase family | 10 | 197 | 8.4E-46 | T | 22-09-2020 | IPR002698 | 5-formyltetrahydrofolate cyclo-ligase |
| UnnamedSample_HQ_transcript/105554|m.23293 | UnnamedSample_HQ_transcript/105554 | Coverage 0.662 too low. | f4631a64de512be9e608b87651aef53d | 200 | Pfam | PF01812 | 5-formyltetrahydrofolate cyclo-ligase family | 10 | 197 | 8.4E-46 | T | 22-09-2020 | IPR002698 | 5-formyltetrahydrofolate cyclo-ligase |
| UnnamedSample_HQ_transcript/104637|m.23186 | UnnamedSample_HQ_transcript/104637 | Coverage 0.642 too low. | f4631a64de512be9e608b87651aef53d | 200 | Pfam | PF01812 | 5-formyltetrahydrofolate cyclo-ligase family | 10 | 197 | 8.4E-46 | T | 22-09-2020 | IPR002698 | 5-formyltetrahydrofolate cyclo-ligase |
| UnnamedSample_HQ_transcript/5894|m.2499 | UnnamedSample_HQ_transcript/5894 | Identity 0.851 too low. | 8b5efe5bd596f9065d362bf0a11d4516 | 665 | Pfam | PF07528 | DZF domain | 534 | 639 | 5.1E-8 | T | 22-09-2020 | IPR006561 | DZF domain |
| UnnamedSample_HQ_transcript/5894|m.2499 | UnnamedSample_HQ_transcript/5894 | Identity 0.851 too low. | 8b5efe5bd596f9065d362bf0a11d4516 | 665 | Pfam | PF12874 | Zinc-finger of C2H2 type | 85 | 108 | 5.8E-6 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5894|m.2499 | UnnamedSample_HQ_transcript/5894 | Identity 0.851 too low. | 8b5efe5bd596f9065d362bf0a11d4516 | 665 | Pfam | PF12874 | Zinc-finger of C2H2 type | 133 | 157 | 1.6E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5894|m.2499 | UnnamedSample_HQ_transcript/5894 | Identity 0.851 too low. | 8b5efe5bd596f9065d362bf0a11d4516 | 665 | Pfam | PF12874 | Zinc-finger of C2H2 type | 284 | 308 | 1.5E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/55632|m.15161 | UnnamedSample_HQ_transcript/55632 | Coverage 0.427 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13499 | EF-hand domain pair | 164 | 221 | 8.6E-8 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/55632|m.15161 | UnnamedSample_HQ_transcript/55632 | Coverage 0.427 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13202 | EF hand | 78 | 94 | 6.1E-4 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/80083|m.19732 | UnnamedSample_HQ_transcript/80083 | Coverage 0.515 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13499 | EF-hand domain pair | 164 | 221 | 8.6E-8 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/80083|m.19732 | UnnamedSample_HQ_transcript/80083 | Coverage 0.515 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13202 | EF hand | 78 | 94 | 6.1E-4 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/79529|m.19630 | UnnamedSample_HQ_transcript/79529 | Coverage 0.568 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13499 | EF-hand domain pair | 164 | 221 | 8.6E-8 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/79529|m.19630 | UnnamedSample_HQ_transcript/79529 | Coverage 0.568 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13202 | EF hand | 78 | 94 | 6.1E-4 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/51721|m.14391 | UnnamedSample_HQ_transcript/51721 | Coverage 0.400 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13499 | EF-hand domain pair | 164 | 221 | 8.6E-8 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/51721|m.14391 | UnnamedSample_HQ_transcript/51721 | Coverage 0.400 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13202 | EF hand | 78 | 94 | 6.1E-4 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/75258|m.18897 | UnnamedSample_HQ_transcript/75258 | Coverage 0.539 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13499 | EF-hand domain pair | 164 | 221 | 8.6E-8 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/75258|m.18897 | UnnamedSample_HQ_transcript/75258 | Coverage 0.539 too low. | fda132839d58f4ae70ef29d7a626b1b3 | 324 | Pfam | PF13202 | EF hand | 78 | 94 | 6.1E-4 | T | 22-09-2020 | IPR002048 | EF-hand domain |
| UnnamedSample_HQ_transcript/32413|m.10056 | UnnamedSample_HQ_transcript/32413 | Coverage 0.123 too low. | ee3639a3fbcb3aa55af642932aa16a7d | 624 | Pfam | PF00069 | Protein kinase domain | 51 | 302 | 3.5E-76 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/10258|m.3907 | UnnamedSample_HQ_transcript/10258 | Identity 0.905 too low. | 1044d7ff692dcb212d7b87c341f96a50 | 1253 | Pfam | PF08399 | VWA N-terminal | 130 | 246 | 1.0E-29 | T | 22-09-2020 | IPR013608 | VWA N-terminal |
| UnnamedSample_HQ_transcript/10258|m.3907 | UnnamedSample_HQ_transcript/10258 | Identity 0.905 too low. | 1044d7ff692dcb212d7b87c341f96a50 | 1253 | Pfam | PF08473 | Neuronal voltage-dependent calcium channel alpha 2acd | 758 | 1075 | 7.1E-18 | T | 22-09-2020 | IPR013680 | Voltage-dependent calcium channel, alpha-2/delta subunit, conserved region |
| UnnamedSample_HQ_transcript/20018|m.6876 | UnnamedSample_HQ_transcript/20018 | Coverage 0.536 too low. | 5c248f31630db0a8383aaea667af17ef | 709 | Pfam | PF13415 | Galactose oxidase, central domain | 281 | 329 | 1.2E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20018|m.6876 | UnnamedSample_HQ_transcript/20018 | Coverage 0.536 too low. | 5c248f31630db0a8383aaea667af17ef | 709 | Pfam | PF06588 | Muskelin N-terminus | 18 | 211 | 3.7E-75 | T | 22-09-2020 | IPR010565 | Muskelin, N-terminal |
| UnnamedSample_HQ_transcript/106776|m.23427 | UnnamedSample_HQ_transcript/106776 | Coverage 0.989 too low. | c9cc8ed03540b41dc456c9be978db06e | 260 | Pfam | PF17903 | Krr1 KH1 domain | 28 | 108 | 4.7E-31 | T | 22-09-2020 | IPR041174 | Krr1, KH1 domain |
| UnnamedSample_HQ_transcript/22394|m.7542 | UnnamedSample_HQ_transcript/22394 | Coverage 0.976 too low. | c71b440ec254e6dd1505557b82fa2fd8 | 269 | Pfam | PF08190 | PIH1 N-terminal domain | 36 | 157 | 9.3E-25 | T | 22-09-2020 | IPR012981 | PIH1, N-terminal |
| UnnamedSample_HQ_transcript/22394|m.7542 | UnnamedSample_HQ_transcript/22394 | Coverage 0.976 too low. | c71b440ec254e6dd1505557b82fa2fd8 | 269 | Pfam | PF18201 | PIH1 CS-like domain | 202 | 267 | 4.5E-8 | T | 22-09-2020 | IPR041442 | PIH1D1/2/3, CS-like domain |
| UnnamedSample_HQ_transcript/94482|m.21873 | UnnamedSample_HQ_transcript/94482 | Coverage 0.788 too low. | 69d9a64bc91e1b35b23e4be858dd5b70 | 327 | Pfam | PF00501 | AMP-binding enzyme | 64 | 327 | 3.5E-55 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/80264|m.19758 | UnnamedSample_HQ_transcript/80264 | Coverage 0.594 too low. | 69d9a64bc91e1b35b23e4be858dd5b70 | 327 | Pfam | PF00501 | AMP-binding enzyme | 64 | 327 | 3.5E-55 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/99928|m.22622 | UnnamedSample_HQ_transcript/99928 | Coverage 0.882 too low. | 69d9a64bc91e1b35b23e4be858dd5b70 | 327 | Pfam | PF00501 | AMP-binding enzyme | 64 | 327 | 3.5E-55 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/93156|m.21688 | UnnamedSample_HQ_transcript/93156 | Coverage 0.896 too low. | 69d9a64bc91e1b35b23e4be858dd5b70 | 327 | Pfam | PF00501 | AMP-binding enzyme | 64 | 327 | 3.5E-55 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/89839|m.21224 | UnnamedSample_HQ_transcript/89839 | Coverage 0.758 too low. | 69d9a64bc91e1b35b23e4be858dd5b70 | 327 | Pfam | PF00501 | AMP-binding enzyme | 64 | 327 | 3.5E-55 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/46972|m.13356 | UnnamedSample_HQ_transcript/46972 | Identity 0.734 too low. | b319c4ba7417c16f417240e556da9218 | 623 | Pfam | PF00271 | Helicase conserved C-terminal domain | 320 | 432 | 3.3E-20 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/46972|m.13356 | UnnamedSample_HQ_transcript/46972 | Identity 0.734 too low. | b319c4ba7417c16f417240e556da9218 | 623 | Pfam | PF00176 | SNF2 family N-terminal domain | 25 | 293 | 6.0E-63 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/10050|m.3847 | UnnamedSample_HQ_transcript/10050 | Coverage 0.324 too low. | 2d11da1cc2490d9bb26042147d9ff490 | 974 | Pfam | PF00665 | Integrase core domain | 526 | 622 | 3.3E-8 | T | 22-09-2020 | IPR001584 | Integrase, catalytic core |
| UnnamedSample_HQ_transcript/11826|m.4435 | UnnamedSample_HQ_transcript/11826 | Coverage 0.350 too low. | 2d11da1cc2490d9bb26042147d9ff490 | 974 | Pfam | PF00665 | Integrase core domain | 526 | 622 | 3.3E-8 | T | 22-09-2020 | IPR001584 | Integrase, catalytic core |
| UnnamedSample_HQ_transcript/3498|m.1616 | UnnamedSample_HQ_transcript/3498 | Coverage 0.876 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 54 | 178 | 2.0E-15 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/3498|m.1616 | UnnamedSample_HQ_transcript/3498 | Coverage 0.876 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 505 | 637 | 3.7E-15 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/3498|m.1616 | UnnamedSample_HQ_transcript/3498 | Coverage 0.876 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 361 | 489 | 3.3E-22 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/9883|m.3787 | UnnamedSample_HQ_transcript/9883 | Coverage 0.830 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 54 | 178 | 2.0E-15 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/9883|m.3787 | UnnamedSample_HQ_transcript/9883 | Coverage 0.830 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 505 | 637 | 3.7E-15 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/9883|m.3787 | UnnamedSample_HQ_transcript/9883 | Coverage 0.830 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 361 | 489 | 3.3E-22 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/43201|m.12532 | UnnamedSample_HQ_transcript/43201 | Coverage 0.795 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 54 | 178 | 2.0E-15 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/43201|m.12532 | UnnamedSample_HQ_transcript/43201 | Coverage 0.795 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 505 | 637 | 3.7E-15 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/43201|m.12532 | UnnamedSample_HQ_transcript/43201 | Coverage 0.795 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 361 | 489 | 3.3E-22 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/7432|m.2997 | UnnamedSample_HQ_transcript/7432 | Coverage 0.941 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 54 | 178 | 2.0E-15 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/7432|m.2997 | UnnamedSample_HQ_transcript/7432 | Coverage 0.941 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 505 | 637 | 3.7E-15 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/7432|m.2997 | UnnamedSample_HQ_transcript/7432 | Coverage 0.941 too low. | 34fe6c8ec4bbb2a33811d8455799532a | 680 | Pfam | PF02469 | Fasciclin domain | 361 | 489 | 3.3E-22 | T | 22-09-2020 | IPR000782 | FAS1 domain |
| UnnamedSample_HQ_transcript/67884|m.17559 | UnnamedSample_HQ_transcript/67884 | Coverage 0.872 too low. | 484a735803df4f99a97095117fb00107 | 113 | Pfam | PF04201 | Tumour protein D52 family | 32 | 97 | 7.5E-17 | T | 22-09-2020 | IPR007327 | Tumour protein D52 |
| UnnamedSample_HQ_transcript/11106|m.4189 | UnnamedSample_HQ_transcript/11106 | Coverage 0.817 too low. | 5f06009277db30a5f53e14f251876ae2 | 1139 | Pfam | PF00595 | PDZ domain | 298 | 368 | 2.1E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11106|m.4189 | UnnamedSample_HQ_transcript/11106 | Coverage 0.817 too low. | 5f06009277db30a5f53e14f251876ae2 | 1139 | Pfam | PF00595 | PDZ domain | 839 | 918 | 2.0E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11106|m.4189 | UnnamedSample_HQ_transcript/11106 | Coverage 0.817 too low. | 5f06009277db30a5f53e14f251876ae2 | 1139 | Pfam | PF00595 | PDZ domain | 477 | 552 | 6.9E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11106|m.4189 | UnnamedSample_HQ_transcript/11106 | Coverage 0.817 too low. | 5f06009277db30a5f53e14f251876ae2 | 1139 | Pfam | PF00595 | PDZ domain | 172 | 254 | 2.5E-15 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11106|m.4189 | UnnamedSample_HQ_transcript/11106 | Coverage 0.817 too low. | 5f06009277db30a5f53e14f251876ae2 | 1139 | Pfam | PF00595 | PDZ domain | 1026 | 1095 | 2.9E-9 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/11106|m.4189 | UnnamedSample_HQ_transcript/11106 | Coverage 0.817 too low. | 5f06009277db30a5f53e14f251876ae2 | 1139 | Pfam | PF00595 | PDZ domain | 673 | 745 | 1.3E-7 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/116352|m.24522 | UnnamedSample_HQ_transcript/116352 | Identity 0.939 too low. | 82c9a079733431853e0f126108ed90c0 | 177 | Pfam | PF13855 | Leucine rich repeat | 41 | 98 | 1.6E-8 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/113020|m.24188 | UnnamedSample_HQ_transcript/113020 | Coverage 0.172 too low. | 0a64be12d681d5bb8f0ecd3bb27dcdba | 188 | Pfam | PF00017 | SH2 domain | 76 | 148 | 6.5E-25 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/41690|m.12198 | UnnamedSample_HQ_transcript/41690 | Coverage 0.697 too low. | 3a1c8cfcf93f8ebaa6a9b7e97d642e3e | 531 | Pfam | PF19056 | WD40 repeated domain | 191 | 419 | 5.2E-61 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/83716|m.20303 | UnnamedSample_HQ_transcript/83716 | Coverage 0.122 too low. | 3ee5a481822cceb93eba8aa3c85a2f0e | 308 | Pfam | PF00012 | Hsp70 protein | 58 | 170 | 4.4E-9 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/55468|m.15126 | UnnamedSample_HQ_transcript/55468 | Coverage 0.624 too low. | 3ee5a481822cceb93eba8aa3c85a2f0e | 308 | Pfam | PF00012 | Hsp70 protein | 58 | 170 | 4.4E-9 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/90799|m.21375 | UnnamedSample_HQ_transcript/90799 | Coverage 0.805 too low. | 3ee5a481822cceb93eba8aa3c85a2f0e | 308 | Pfam | PF00012 | Hsp70 protein | 58 | 170 | 4.4E-9 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/56207|m.15282 | UnnamedSample_HQ_transcript/56207 | Coverage 0.841 too low. | 3ee5a481822cceb93eba8aa3c85a2f0e | 308 | Pfam | PF00012 | Hsp70 protein | 58 | 170 | 4.4E-9 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/17048|m.6021 | UnnamedSample_HQ_transcript/17048 | Identity 0.939 too low. | 84617772cbe15d3f11082df61d9d210c | 1096 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 659 | 915 | 5.3E-45 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/17048|m.6021 | UnnamedSample_HQ_transcript/17048 | Identity 0.939 too low. | 84617772cbe15d3f11082df61d9d210c | 1096 | Pfam | PF14529 | Endonuclease-reverse transcriptase | 90 | 231 | 4.6E-10 | T | 22-09-2020 | IPR005135 | Endonuclease/exonuclease/phosphatase |
| UnnamedSample_HQ_transcript/118724|m.24747 | UnnamedSample_HQ_transcript/118724 | Coverage 0.988 too low. | 8700adc8a416c4c4064f31ee0e2559ee | 192 | Pfam | PF00135 | Carboxylesterase family | 14 | 163 | 5.2E-15 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/84400|m.20400 | UnnamedSample_HQ_transcript/84400 | Coverage 0.806 too low. | a7882d6a3c5daae67df51a2ae8c88b6f | 227 | Pfam | PF00501 | AMP-binding enzyme | 3 | 197 | 1.2E-46 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/87092|m.20811 | UnnamedSample_HQ_transcript/87092 | Coverage 0.248 too low. | 04eb2b4f439c0fe42efabe8a3d8db9ad | 354 | Pfam | PF07690 | Major Facilitator Superfamily | 26 | 284 | 3.8E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/61291|m.16323 | UnnamedSample_HQ_transcript/61291 | Coverage 0.533 too low. | ee9c51e51941f7888848528562e2fc1f | 521 | Pfam | PF02881 | SRP54-type protein, helical bundle domain | 202 | 272 | 6.9E-10 | T | 22-09-2020 | IPR013822 | Signal recognition particle SRP54, helical bundle |
| UnnamedSample_HQ_transcript/61291|m.16323 | UnnamedSample_HQ_transcript/61291 | Coverage 0.533 too low. | ee9c51e51941f7888848528562e2fc1f | 521 | Pfam | PF00448 | SRP54-type protein, GTPase domain | 303 | 520 | 7.8E-50 | T | 22-09-2020 | IPR000897 | Signal recognition particle, SRP54 subunit, GTPase domain |
| UnnamedSample_HQ_transcript/61291|m.16323 | UnnamedSample_HQ_transcript/61291 | Coverage 0.533 too low. | ee9c51e51941f7888848528562e2fc1f | 521 | Pfam | PF04086 | Signal recognition particle, alpha subunit, N-terminal | 5 | 180 | 2.3E-16 | T | 22-09-2020 | IPR007222 | Signal recognition particle receptor, alpha subunit, N-terminal |
| UnnamedSample_HQ_transcript/11067|m.4170 | UnnamedSample_HQ_transcript/11067 | Identity 0.901 too low. | e71ac71cee5f7b2d4ace11bc3bea8a2e | 913 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 359 | 408 | 8.1E-11 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/11067|m.4170 | UnnamedSample_HQ_transcript/11067 | Identity 0.901 too low. | e71ac71cee5f7b2d4ace11bc3bea8a2e | 913 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 96 | 147 | 1.7E-7 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/11067|m.4170 | UnnamedSample_HQ_transcript/11067 | Identity 0.901 too low. | e71ac71cee5f7b2d4ace11bc3bea8a2e | 913 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 51 | 93 | 1.7E-5 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/11067|m.4170 | UnnamedSample_HQ_transcript/11067 | Identity 0.901 too low. | e71ac71cee5f7b2d4ace11bc3bea8a2e | 913 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 152 | 200 | 1.2E-13 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/11067|m.4170 | UnnamedSample_HQ_transcript/11067 | Identity 0.901 too low. | e71ac71cee5f7b2d4ace11bc3bea8a2e | 913 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 203 | 252 | 4.9E-13 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/11067|m.4170 | UnnamedSample_HQ_transcript/11067 | Identity 0.901 too low. | e71ac71cee5f7b2d4ace11bc3bea8a2e | 913 | Pfam | PF00415 | Regulator of chromosome condensation (RCC1) repeat | 258 | 305 | 1.5E-10 | T | 22-09-2020 | IPR000408 | Regulator of chromosome condensation, RCC1 |
| UnnamedSample_HQ_transcript/11067|m.4170 | UnnamedSample_HQ_transcript/11067 | Identity 0.901 too low. | e71ac71cee5f7b2d4ace11bc3bea8a2e | 913 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 586 | 891 | 3.3E-59 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/75126|m.18868 | UnnamedSample_HQ_transcript/75126 | Coverage 0.713 too low. | 2aa8bcc610a2ec3c770e6cef9f274e82 | 242 | Pfam | PF00907 | T-box | 59 | 239 | 2.4E-85 | T | 22-09-2020 | IPR001699 | Transcription factor, T-box |
| UnnamedSample_HQ_transcript/75126|m.18868 | UnnamedSample_HQ_transcript/75126 | Coverage 0.713 too low. | 2aa8bcc610a2ec3c770e6cef9f274e82 | 242 | Pfam | PF11078 | Optomotor-blind protein N-terminal region | 2 | 47 | 2.5E-8 | T | 22-09-2020 | IPR021101 | Optomotor-blind protein, N-terminal |
| UnnamedSample_HQ_transcript/3802|m.1735 | UnnamedSample_HQ_transcript/3802 | Coverage 0.952 too low. | 628e383fc27a2c30865d0c726c48b5fa | 541 | Pfam | PF08725 | Integrin beta cytoplasmic domain | 495 | 538 | 7.6E-22 | T | 22-09-2020 | IPR014836 | Integrin beta subunit, cytoplasmic domain |
| UnnamedSample_HQ_transcript/3802|m.1735 | UnnamedSample_HQ_transcript/3802 | Coverage 0.952 too low. | 628e383fc27a2c30865d0c726c48b5fa | 541 | Pfam | PF00362 | Integrin beta chain VWA domain | 1 | 129 | 5.6E-53 | T | 22-09-2020 | IPR002369 | Integrin beta subunit, VWA domain |
| UnnamedSample_HQ_transcript/3802|m.1735 | UnnamedSample_HQ_transcript/3802 | Coverage 0.952 too low. | 628e383fc27a2c30865d0c726c48b5fa | 541 | Pfam | PF07965 | Integrin beta tail domain | 391 | 468 | 1.1E-13 | T | 22-09-2020 | IPR012896 | Integrin beta subunit, tail |
| UnnamedSample_HQ_transcript/3802|m.1735 | UnnamedSample_HQ_transcript/3802 | Coverage 0.952 too low. | 628e383fc27a2c30865d0c726c48b5fa | 541 | Pfam | PF18372 | Integrin beta epidermal growth factor like domain 1 | 223 | 247 | 7.9E-8 | T | 22-09-2020 | IPR040622 | Integrin beta, epidermal growth factor-like domain 1 |
| UnnamedSample_HQ_transcript/38881|m.11596 | UnnamedSample_HQ_transcript/38881 | Coverage 0.968 too low. | cc80768554000fcbff934f85cb63e9d9 | 656 | Pfam | PF00856 | SET domain | 237 | 519 | 4.5E-12 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/37647|m.11309 | UnnamedSample_HQ_transcript/37647 | Coverage 0.600 too low. | 61d99a39ade0e4c57a471382a6a8a909 | 668 | Pfam | PF09820 | Predicted AAA-ATPase | 54 | 396 | 1.8E-22 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/48271|m.13641 | UnnamedSample_HQ_transcript/48271 | Coverage 0.546 too low. | 61d99a39ade0e4c57a471382a6a8a909 | 668 | Pfam | PF09820 | Predicted AAA-ATPase | 54 | 396 | 1.8E-22 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/41493|m.12157 | UnnamedSample_HQ_transcript/41493 | Coverage 0.945 too low. | 63e0252cc53b441a37a82faada56c549 | 321 | Pfam | PF08282 | haloacid dehalogenase-like hydrolase | 3 | 45 | 5.6E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/41493|m.12157 | UnnamedSample_HQ_transcript/41493 | Coverage 0.945 too low. | 63e0252cc53b441a37a82faada56c549 | 321 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 85 | 288 | 2.3E-43 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/78645|m.19489 | UnnamedSample_HQ_transcript/78645 | Identity 0.932 too low. | 03518c7cafeb300fed8b1fc1f78849d1 | 530 | Pfam | PF03723 | Hemocyanin, ig-like domain | 267 | 521 | 1.6E-78 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/78645|m.19489 | UnnamedSample_HQ_transcript/78645 | Identity 0.932 too low. | 03518c7cafeb300fed8b1fc1f78849d1 | 530 | Pfam | PF00372 | Hemocyanin, copper containing domain | 18 | 258 | 9.5E-68 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/30298|m.9544 | UnnamedSample_HQ_transcript/30298 | Identity 0.841 too low. | 6e058a4064e9e8e29d624edb729d3713 | 640 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 240 | 297 | 8.5E-23 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/30298|m.9544 | UnnamedSample_HQ_transcript/30298 | Identity 0.841 too low. | 6e058a4064e9e8e29d624edb729d3713 | 640 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 343 | 639 | 2.7E-60 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/50303|m.14086 | UnnamedSample_HQ_transcript/50303 | Identity 0.799 too low. | 6e058a4064e9e8e29d624edb729d3713 | 640 | Pfam | PF00658 | Poly-adenylate binding protein, unique domain | 240 | 297 | 8.5E-23 | T | 22-09-2020 | IPR002004 | Polyadenylate-binding protein/Hyperplastic disc protein |
| UnnamedSample_HQ_transcript/50303|m.14086 | UnnamedSample_HQ_transcript/50303 | Identity 0.799 too low. | 6e058a4064e9e8e29d624edb729d3713 | 640 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 343 | 639 | 2.7E-60 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/79708|m.19658 | UnnamedSample_HQ_transcript/79708 | Coverage 0.918 too low. | 6b18c56c1e97067f71c8a8330fc88b4d | 438 | Pfam | PF00579 | tRNA synthetases class I (W and Y) | 30 | 337 | 4.6E-68 | T | 22-09-2020 | IPR002305 | Aminoacyl-tRNA synthetase, class Ic |
| UnnamedSample_HQ_transcript/75174|m.18878 | UnnamedSample_HQ_transcript/75174 | Coverage 0.947 too low. | 6b18c56c1e97067f71c8a8330fc88b4d | 438 | Pfam | PF00579 | tRNA synthetases class I (W and Y) | 30 | 337 | 4.6E-68 | T | 22-09-2020 | IPR002305 | Aminoacyl-tRNA synthetase, class Ic |
| UnnamedSample_HQ_transcript/14291|m.5193 | UnnamedSample_HQ_transcript/14291 | Coverage 0.110 too low. | 1d766a07a32079065545e4ddc230d734 | 693 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 89 | 211 | 1.9E-9 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/6053|m.2558 | UnnamedSample_HQ_transcript/6053 | Identity 0.713 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/6053|m.2558 | UnnamedSample_HQ_transcript/6053 | Identity 0.713 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/4798|m.2114 | UnnamedSample_HQ_transcript/4798 | Identity 0.728 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/4798|m.2114 | UnnamedSample_HQ_transcript/4798 | Identity 0.728 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/4229|m.1889 | UnnamedSample_HQ_transcript/4229 | Identity 0.739 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/4229|m.1889 | UnnamedSample_HQ_transcript/4229 | Identity 0.739 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/3724|m.1703 | UnnamedSample_HQ_transcript/3724 | Identity 0.745 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/3724|m.1703 | UnnamedSample_HQ_transcript/3724 | Identity 0.745 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/4917|m.2160 | UnnamedSample_HQ_transcript/4917 | Identity 0.722 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/4917|m.2160 | UnnamedSample_HQ_transcript/4917 | Identity 0.722 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/4249|m.1896 | UnnamedSample_HQ_transcript/4249 | Identity 0.734 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/4249|m.1896 | UnnamedSample_HQ_transcript/4249 | Identity 0.734 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 7.5E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/4658|m.2056 | UnnamedSample_HQ_transcript/4658 | Identity 0.731 too low. | 08e1d707ddb6f5d77eade4e47d816076 | 1461 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 6.4E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
